Skip to content

SEARCH

Investing News
Featured
Market
Biotech
Oil & Gas
Financial
Health
MORE
- Health
- Entertainment
- Real Estate
- Cannabis
- ESG
- Financial
- Industrials
- Food & Beverage

Search

SEARCH FOR AN ARTICLE

Search

Investing News
Featured
Market
Biotech
Oil & Gas
Financial
Health
MORE
- Health
- Entertainment
- Real Estate
- Cannabis
- ESG
- Financial
- Industrials
- Food & Beverage

HomeCRDL-PR-17

CRDL-PR-17

Cardiol Therapeutics Receives FDA Approval for Investigational New Drug (IND) Application for Phase II/III COVID-19 Trial

Cardiol Therapeutics Receives FDA Approval for Investigational New Drug (IND) Application for Phase II/III COVID-19 Trial

September 25, 2020

LATEST NEWS

All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

Advertisers
Privacy Policy
Terms of Use
DMCA Policy
Disclaimer
Contact Us

SUBSCRIBE

To get email updates from Stock Street News.

I want e-mail alerts, updates, and offers and agree to the StockStreetNews privacy policy.

Market Jar Media Inc. © 2024